Search - tctmd.com

Displaying 381 - 400 of 503

Sort: Relevancy | Date

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Occurrence of Left Ventricular Reverse Remodeling After Transcatheter Aortic Valve Replacement: Analysis of a Brazilian Cohort

Presenter: Fabiula Azevedo

June 13, 2019

Presentation TVT 2019

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Presenter: Sarah Gualano

June 13, 2019

Presentation TVT 2019

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Presenter: Karim Al-Azizi

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Presentation TVT 2019

Selective Use — Is There a Middle Ground?

Presenter: Jeffrey Moses

June 13, 2019

Presentation TVT 2019

Not Necessary — Soft Data and Excessive Costs!

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Systematic — In All Patients, Whenever Possible!

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

Successful BASILICA for a Failed CoreValve

Presenter: Ikki Komatsu

June 13, 2019

Presentation TVT 2019

Percutaneous Aortic Valve Replacement: Life-Threatening Complication and Out-of-the-Box Solution

Presenter: Nagendra Chouhan

June 13, 2019

Presentation TVT 2019

Controversies Around PPM: Its Estimation and When Does it Matter?

Presenter: Philippe Pibarot

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

Presentation TVT 2019

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Presenter: Samir Kapadia

June 13, 2019

Advertisement

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Occurrence of Left Ventricular Reverse Remodeling After Transcatheter Aortic Valve Replacement: Analysis of a Brazilian Cohort

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Selective Use — Is There a Middle Ground?

Not Necessary — Soft Data and Excessive Costs!

Systematic — In All Patients, Whenever Possible!

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

Successful BASILICA for a Failed CoreValve

Percutaneous Aortic Valve Replacement: Life-Threatening Complication and Out-of-the-Box Solution

Controversies Around PPM: Its Estimation and When Does it Matter?

Status Updates on the Next Generation of Cerebral Protection Devices

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content